Diagnostic and prognostic value of bone biomarkers in progressive knee osteoarthritis: A 6-year follow-up study in middle-aged subjects

Osteoarthritis and Cartilage

Volumn 21, Issue 6, 2013, Pages 815-822

  Kumm, J ^a   Tamm, A ^a   Lintrop, M ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Bone markers; Knee; Osteoarthritis; Osteophyte; Radiographic progression

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE METABOLISM; BONE MINERALIZATION; CHEMILUMINESCENCE IMMUNOASSAY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; JOINT; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OSSIFICATION; OSTEOLYSIS; OSTEOPHYTE; PATELLOFEMORAL JOINT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RISK FACTOR; TIBIOFEMORAL JOINT;

ADULT; BIOLOGICAL MARKERS; BONE RESORPTION; COLLAGEN TYPE I; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OSTEOCALCIN; OSTEOGENESIS; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN;

EID: 84877157461     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.03.008     Document Type: Article

References (39)

1. Felson D.T. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009, 11(1):203.
2. Brandt K.D., Doherty M., Lohmander L.S. Introduction: the concept of osteoarthritis as failure of the diarthrodial joint. Osteoarthritis 2003, 69-71. Oxford University Press, New York. K.D. Brandt, M. Doherty, L.S. Lohmander (Eds.).
3. Senior K. Osteoarthritis research: on the verge of a revolution?. Lancet 2000, 355(9199):208.
4. Mastbergen S.C., Lafeber F.P. Changes in subchondral bone early in the development of osteoarthritis. Arthritis Rheum 2011, 63(9):2561-2563.
5. Bailey A.J., Buckland-Wright C., Metz D. The role of bone in osteoarthritis. Age Ageing 2001, 30(5):374-378.
6. Anderson MacKenzie J.M., Quasnichka H.L., Starr R.L., Lewis E.J., Billingham M.E., Bailey A.J. Fundamental subchondral bone changes in spontaneous knee osteoarthritis. Int J Biochem Cell Biol 2005, 37(1):224-236.
7. Hayami T., Pickarski M., Zhuo Y., Wesolowski G.A., Rodan G.A., Duong le T. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006, 38(2):234-243.
8. Spector T.D., Conaghan P.G., Buckland-Wright J.C., Garnero P., Cline G.A., Beary J.F., et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther 2005, 7(3):R625-R633.
9. Iwamoto J., Takeda T., Sato Y., Matsumoto H. Effects of risedronate on osteoarthritis of the knee. Yonsei Med J 2010, 51(2):164-170.
10. Garnero P., Piperno M., Gineyts E., Christgau S., Delmas P.D., Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001, 60(6):619-626.
11. Petersson I.F., Boegard T., Svensson B., Heinegard D., Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998, 37:46-50.
12. Otterness I.G., Swindell A.C., Zimmerer R.O., Poole A.R., Ionescu M., Weiner E. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage 2000, 8:180-185.
13. Naitou K., Kushida K., Takahashi M., Ohishi T., Inoue T. Bone mineral density and bone turnover in patients with knee osteoarthritis compared with generalized osteoarthritis. Calcif Tissue Int 2000, 66:325-329.
14. Bettica P., Cline G., Hart D.J., Meyer J., Spector T.D. Evidence for increased bone resorption in patients with progressive knee osteoarthritis. Arthritis Rheum 2002, 46:3178-3184.
15. Sowers M., Lachance L., Jamadar D., Hochberg M., Hollis B., Crutchfield M., et al. The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum 1999, 42:483-489.
16. Ivaska K.K., Käkönen S., Gerdhem P., Obrant K.J., Petersson K., Väänänen K. Urinary osteocalcin as a marker of bone metabolism. Clin Chem 2005, 51:618-628.
17. Srivastava A.K., Mohan S., Singer F.R., Baylink D.J. Aurine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients. Bone 2002, 31:62-69.
18. Ivaska K.K., Petersson K., Nenonen K., Uusi-Rasi K., Heinonen A., Kannus P., et al. Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy. Clin Chem 2005, 51(12):2362-2365.
19. Kumm J., Ivaska K.K., Rohtla K., Väänänen K., Tamm A. Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy. Scand J Clin Lab Invest 2008, 68(6):459-463.
20. Garnero P. Noninvasive biochemical markers in osteoarthritis. Osteoarthritis. Diagnosis and Medical/surgical Management 2007, 215-232. Lippincott Williams & Wilkins, Philadelphia. 4th edn. R.W. Moskowitz, R.D. Altman, M.C. Hochberg, J.A. Buckwalter, V. Goldberg (Eds.).
21. Berry P.A., Maciewicz R.A., Cicuttini F.M., Jones M.D., Hellawell C.J., Wluka A.E. Markers of bone formation and resorption identify subgroups of patients with clinical knee osteoarthritis who have reduced rates of cartilage loss. JRheumatol 2010, 37(6):1252-1259.
22. Tamm A., Lintrop M., Veske K., Hansen U., Tamm A. Prevalence of patello- and tibiofemoral osteoarthritis in Elva, Southern Estonia. JRheumatol 2008, 35:543-544.
23. Boegard T., Rudling O., Petersson I.F., Sanfridsson J., Saxne T., Svensson B., et al. Joint-space width in the axial view of the patello-femoral joint. Definitions and comparison with MR imaging. Acta Radiol 1998, 39:24-31.
24. Nagaosa Y., Mateus M., Hassan B., Lanyon B., Doherty M. Development of logically devised line drawing atlas forgrading of knee osteoarthritis. Ann Rheum Dis 2000, 59:587-595.
25. Botha-Scheepers S., Watt I., Breedveld F.C., Kloppenburg M. Reading radiographs in pairs or in chronological order influences radiological progression in osteoarthritis. Rheumatology 2005, 44:1452-1455.
26. Kumm J., Tamm A.E., Lintrop M., Tamm A.O. The prevalence and progression of radiographic knee osteoarthritis over 6 years in a population-based cohort of middle-aged subjects. Rheumatol Int 2011, 10.1007/s00296-011-2221-3.
27. Ivaska K.K., Hentunen T.A., Vääräniemi J., Ylipahkala H., Pettersson K., Väänänen H.K. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption invitro. JBiol Chem 2004, 18:18361-18369.
28. Bruyere O., Collette J., Kothari M., Zaim S., White D., Genant H., et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 2006, 65(8):1050-1054.
29. Jordan K.M., Syddall H.E., Garnero P., Gineyts E., Dennison E.M., Sayer A.A., et al. Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 2006, 65(7):871-877.
30. Robey P.G., Boskey A.L. The composition of bone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2008, 32-38. American Society for Bone and Mineral Research, The Sheridan Press, Washington, DC. 7th edn. C.J. Rosen (Ed.).
31. Altman R.D., Gold G.E. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 2007, 15(Suppl A):A1-A56.
32. Spector T.D., Hart D.J., Byrne J., Harris P.A., Dacre J.E., Doyle D.V. Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis 1993, 52(11):790-794.
33. Kraus V.B. Osteoarthritis year 2010 in review: biochemical markers. Osteoarthritis Cartilage 2011, 19:346-353.
34. van Spil W.E., DeGroot J., Lems W.F., Oostveen J.C., Lafeber F.P. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systemic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 2010, 18:605-612.
35. Hashimoto S., Creighton-Achermann L., Takahashi K., Amiel D., Coutts R.D., Lotz M. Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2002, 10:180-187.
36. Blaney Davidson E.N., Vitters E.L., van Beuningen H.M., van de Loo F.A.J., van den Berg W.B., van der Kraan P.M. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 2007, 56:4065-4073.
37. Kumm J., Tamm A.E., Lintrop M., Tamm A.O. Associations between ultrasonographic findings and bone/cartilage biomarkers in patients with early-stage knee osteoarthritis. Calcif Tissue Int 2009, 85:514-522.
38. Kumm J., Tamm A.E., Veske K., Lintrop M., Tamm A.O. Associations between cartilage oligomeric matrix protein and several articular tissues in early knee joint osteoarthritis. Rheumatology 2006, 45:1308-1309.
39. Kumm J., Tamm A., Lintrop M., Tamm A. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and six years follow-up study in middle-aged subjects. Rheumatol Int 2012, 10.1007/s00296-012-2463-8.